| Efficacy and safety of molnupiravir in mild COVID-19 patients in India S Sinha, N Kumarasamy, VK Suram, SS Chary, S Naik, VB Singh, ... Cureus 14 (11), 2022 | 19 | 2022 |
| Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized … SD Sinha, VK Bandi, BR Bheemareddy, P Thakur, S Chary, K Mehta, ... BMC nephrology 20, 1-9, 2019 | 17 | 2019 |
| Statins: Can we advocate them for primary prevention of heart disease? S Ray, AK Jindal, S Sengupta, S Sinha medical journal armed forces india 70 (3), 270-273, 2014 | 17 | 2014 |
| Phase III trial of molnupiravir in adults with mild SARS-CoV-2 infection in India N Kumarasamy, B Saha, A Jindal, VB Singh, NC Reddy Podduturi, ... Topics in Antiviral Medicine, 39-39, 2022 | 8 | 2022 |
| Darbepoetin alfa versus erythropoietin alfa for treatment of renal anemia in patients with chronic kidney disease at the pre-dialysis stage: a randomized non-inferiority trial KS Mehta, SD Sinha, B Vamsi, B Reddy, NR Naidu, PA Thakur, ... The Journal of the Association of Physicians of India 67 (1), 62-66, 2019 | 7 | 2019 |
| A prospective, randomized, multiple-dose, multi-center, comparative clinical study to evaluate the efficacy, safety, immunogenicity of a biosimilar bevacizumab (test product … S Advani, G Biswas, S Sinha, VK Bandi, N Naidu, P Thakur, S Chary The Journal of the Association of Physicians of India 66 (6), 55-59, 2018 | 7 | 2018 |
| Efficacy and safety of acotiamide versus mosapride in patients with functional dyspepsia associated with meal-induced postprandial distress syndrome: a phase III randomized … S Sinha, S Chary, P Thakur, L Talluri, M Reddy, JM Mohan, P Jain, S Naik, ... Cureus 13 (9), 2021 | 5 | 2021 |
| Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in … S Sinha, B Ghosh, S Bandyopadhyay, F Fatima, VK Bandi, P Thakur, ... BMC rheumatology 4, 1-11, 2020 | 5 | 2020 |
| Air Permeability of nonwoven filter fabrics KN Chatterjee, S Sinha, SC Jhalani, BP Mani Indian Textile Journal 102, 102-102, 1992 | 5 | 1992 |
| Evaluation of the Efficacy and Safety of Azilsartan in Adult Patients with Essential Hypertension: A Randomized, Phase-III Clinical Study in India. S Sinha, S Chary, P Thakur, L Talluri, VK Reddy, M Agarwal, KS Naik The Journal of the Association of Physicians of India 69 (2), 35-39, 2021 | 4 | 2021 |
| A phase III prospective active and placebo-controlled randomized trial of vilazodone in the treatment of major depressive disorder S Sinha, S Chary, P Thakur, L Talluri, M Reddy, KK Verma, P Saha, ... Cureus 13 (7), 2021 | 3 | 2021 |
| Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind … SD Sinha, SK Sinha, L Talluri, RK Bhashyakarla, U Malladi, RV Dosi, ... Cureus 13 (4), 2021 | 1 | 2021 |
| Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a … SD Sinha, VK Bandi, BR Bheemareddy, P Thakur, S Chary, K Mehta, ... BMC nephrology 20, 1-5, 2019 | 1 | 2019 |
| Efficacy and safety of fixed-dose combination of Bilastine-Montelukast in adult patients with allergic rhinitis: a phase III, randomized, multi-center, double-blind, active … SD Sinha, S Perapogu, S Chary S, S Ramesh, J Bakshi, A Singh, ... Journal of Asthma 60 (11), 2014-2020, 2023 | | 2023 |
| Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult … SD Sinha, A Rajamma, MR Bandi, SC Sriramadasu, S Sahu, ... Clinical Drug Investigation 43 (7), 565-574, 2023 | | 2023 |
| A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India SD Sinha, G Biswas, BR Bheemareddy, S Chary, P Thakur, M Jain, ... Cancer Informatics 22, 11769351231177277, 2023 | | 2023 |
| TOCILIZUMAB (BIOSIMILAR) USE in CYTOKINE STORM of SEVERE COVID-19 PNEUMONIA N Kumarasamy, SV Maruti, S Maheshwari, A Nikalje, CC Rathod, MK Jain, ... Topics in Antiviral Medicine, 250-250, 2022 | | 2022 |
| Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing … SD Sinha, VK Bandi, BB Reddy, P Thakur, S Chary, L Talluri, ... Cureus 13 (4), 2021 | | 2021 |
| Safety and tolerability of prescribed usage of Derise®(Darbepoetin Alfa, Hetero) in symptomatic anemia: A Post Marketing Surveillance Study S Sinha, VK Bandi, BR Bheemareddy, P Thakur, S Chary, L Talluri, ... | | 2020 |
| Safety and tolerability of prescribed usage of Derise®(Darbepoetin Alfa, Hetero) in symptomatic anemia: A Phase IV Post-Authorization Study S Sinha, VK Bandi, BR Bheemareddy, P Thakur, S Chary, L Talluri, ... | | 2020 |
